Zunini-Fernández G, Rando-Huluk K, Martínez-Pelayo FJ, Castillo-Trevizo AL

Idioma: Español
Referencias bibliográficas: 40
Paginas: 473-480
Archivo PDF: 381.06 Kb.

RESUMEN

La hemorragia masiva es una de las principales causas de muerte y paro cardiaco intraoperatorio. Su mortalidad varía entre 15 y 54%. La presencia de acidosis, hipotermia y coagulopatía son elementos de pronóstico ominoso. En esta revisión se describen las causas que perpetuán la hemorragia en el sangrado masivo, las particularidades del daño tisular controlado y no controlado, el valor de los exámenes de laboratorio para el diagnóstico de coagulopatía, y las guías actuales del manejo con líquidos y hemoderivados. La respuesta frente al sangrado requiere una adecuada comunicación del equipo quirúrgico con el banco de sangre, para así asegurar el suministro de los hemocomponentes adecuados en cantidad y calidad, instalación de medidas para evitar la hipotermia y disponibilidad de sistemas de infusión rápida.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Irita K, Inada E, Yoshimura H, Warabi K, Tsuzaki K, Inaba S, et al. Present status of preparatory measures for massive hemorrhage and emergency blood transfusion in regional hospitals with an accredited department of anesthesiology in 2006. Masui 2009;58:109-123.

2. Irita K, Yoshimura H, Sakaguchi Y, Takamatsu C, Tokuda K. Risk and crisis management by anesthesiologists regarding 'Guidelines for Actions Against Intraoperative Critical Hemorrhage' published by the Japanese Society of Anesthesiologists and the Japan Society of Transfusion Medicine and Cell Therapy. Masui 2008;57:1109-1116.

3. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2006;53:S40-58.

4. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernández-Mondejar E, Gordini G, et al. Management of bleeding following major trauma: a European guideline. Crit Care 2007;11:R17.

5. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007;73:401-415.

6. Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005;89:123-127.

7. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009;197:565-570; discussion 570.

8. Teixeira PG, Inaba K, Shulman I, Salim A, Demetriades D, Brown C, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009;66:693-697.

9. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009;96:111-118.

10. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-196.

11. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007;62:112-119.

12. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;20:1402-1405.

13. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg 2006;102:1280-1284.

14. Yoshihara H, Yamamoto T, Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res 1985;37:503-512.

15. Leslie SD, Toy PT. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991;96:770-773.

16. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.

17. Simmons RL, Collins JA, Heisterkamp CA, Mills DE, Andren R, Phillips LL. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Postresuscitative changes. Ann Surg 1969;169:455-482.

18. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997;42:857-861; discussion 861-862.

19. Gando S, Tedo I, Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med 1992;20:594-600.

20. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 1995;23:1835-1842.

21. Hardy JF, De Moerloose P, Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004;51:293-310.

22. Miller RD, Robbins TO, Tong MJ, Barton SL. Coagulation defects associated with massive blood transfusions. Ann Surg 1971;174:794-801.

23. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.

24. Dutton RP. Current concepts in hemorrhagic shock. Anesthesiol Clin 2007;25:23-34.

25. DeLoughery TG. Coagulation defects in trauma patients: etiology, recognition, and therapy. Crit Care Clin 2004;20:13-24.

26. Stern SA. Low-volume fluid resuscitation for presumed hemorrhagic shock: helpful or harmful? Curr Opin Crit Care 2001;7:422-430.

27. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-1109.

28. Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess 2000;4:1-57.

29. Sampalis JS, Tamim H, Denis R, Boukas S, Ruest SA, Nikolis A, et al. Ineffectiveness of on-site intravenous lines: is prehospital time the culprit? J Trauma 1997;43:608-615; discussion 615-617.

30. Burris D, Rhee P, Kaufmann C, Pikoulis E, Austin B, Eror A, et al. Controlled resuscitation for uncontrolled hemorrhagic shock. J Trauma 1999;46:216-223.

31. Kwan I, Bunn F, Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 2003:CD002245.

32. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008;109:723-740.

33. Ribeiro MA Jr, Epstein MG, Alves LD. Volume replacement in trauma. Ulus Travma Acil Cerrahi Derg 2009;15:311-316.

34. Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002;88:475-480.

35. Rando K, Zunini G, Negroto A. Intraoperative hyponatremia during craniofacial surgery. Paediatr Anaesth 2009;19:358-363.

36. Strauss RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 1981;21:299-302.

37. de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-290.

38. Boldt J. Use of albumin: an update. Br J Anaesth 2010;104:276-284.

39. Johansson PI. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials. Vox Sang 2008;95:1-7.

40. Dutton RP, Conti BM. The role of recombinant-activated factor VII in bleeding trauma patients. Curr Opin Anaesthesiol 2009;22:299-304.